Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma withRPLNrecurrence
Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma withRPLNrecurrence
复制标题
经宫颈内镜咽后淋巴结（RPLN）切除术治疗鼻咽癌伴RPLN复发
DOI：
10.1002/hed.26459
复制
发表时间：
2020-09-28
影响因子：
2.9
通讯作者：
Chen, Ming-Yuan
中科院分区：
文献类型：
--
作者：
Liu, You-Ping;Wang, Shun-Lan;Chen, Ming-Yuan
Background Surgical access for retropharyngeal lymph node (RPLN) dissection is difficult. We aimed to examine the efficacy of transcervical endoscopic RPLN dissection (TSE-RPLND) for recurrent RPLN in nasopharyngeal carcinoma (NPC). Methods From April 2013 to February 2019, a total of 31 patients with NPC diagnosed with RPLN recurrence underwent TSE-RPLND. The clinical characteristics, complications, and survival outcomes were retrospectively analyzed. Results The mean duration of surgery, quantity of bleeding and postoperative hospitalization stay were 347.9 minutes, 107.7 mL, and 8.7 days, respectively. After a median follow-up of 31.0 months, the 2-year locoregional relapse-free survival, distant metastasis-free survival, progression-free survival, and overall survival rates were 63.9%, 95.2%, 59.9%, and 83.3%, respectively. The long-term incidences of swallowing problems, permanent nutrient tube, tongue atrophy, and shoulder problems were 6 (19.4%), 3 (9.7%), 3 (9.7%), and 3 (9.7%), respectively. Conclusions TSE-RPLND is an effective method to treat RPLN recurrence in NPC, but nerve injury-related complications should not be ignored.
